Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Lung cancer, non-small cell
Treatment/Intervention:  complementary or alternative medicine procedure
Trial Status:  Active
Results 1-25 of 29 for your search:
Start Over
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
Phase: Phase IV
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: yl-yxb08-lcsyfa-201302, NCT02195453
Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
Additive Homeopathy in Cancer Patients
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 5, NCT01509612
Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 97-1967A3, NCT01802021
Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SV-001 and SV-002, SFC-SV001, SFC-01-0150-0001-02-CM, SFC-01-0150-001, SFC-SV002, NCT00246727
Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007077-01H, NCT00668707
Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients
Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LC 001, NCT01441752
Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: UMAN-10-01, NCT01628471
Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue(CRF)
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CIM2013-F, NCT01881516
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GHNSCLC-2 001, NCT02047344
Pharmacological Ascorbate for Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201412760, 3P30CA086862, NCT02420314
Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644401, UPCC-03309, IRB# 806733, NCT00955942
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2013-021, NCI-2013-01835, 1307012220, P30CA022453, NCT01958372
Acupuncture Feasibility Trial for Dyspnea in Lung Cancer
Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 11513, NCT02094950
A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: JGH-14-149, NCT02321293
A Feasibility Study of Chinese Herbs to Manage Cancer-related Symptoms in Patients With Advanced NSCLC
Phase: Phase I
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: JGH-14-150, NCT02331394
Yoga-Based Cancer Rehabilitation Program
Phase: No phase specified
Type: Behavioral study, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: #2000-007, NCI R03 CA88598-01A1, NCT00179348
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08.0041, BCC-LUN-07-005, NCT00682032
Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions
Phase: No phase specified
Type: Diagnostic
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2010-no-emn, NCT00880945
Short-Term Fasting: Impact on Toxicity
Phase: No phase specified
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 0S-08-9, NCT00936364
Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KCRC-IRB-2011009 & L-2011-170, NCT01408212
Mindfulness for Lung Cancer Patients and Partners
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MFN 2011-2015, NCT01494883
Survey on Chinese Medicine Syndrome for Patients With Non Small Cell Lung Cancer
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KCC(QEH)/HKBU/NSCLC2012, NCT01681485
Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Active
Age: 65 to 80
Sponsor: Other
Protocol IDs: 12401905700zzy, NCT01780181
Start Over